Heart rate slowing for myocardial dysfunction/heart failure: Rationale and preclinical studies

Advances in Cardiology

Volumn 43, Issue , 2006, Pages 97-105

  Mulder, Paul ^a   Thuillez, Christian ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BENZAZEPINE DERIVATIVE; CARDIOTONIC AGENT; ION CHANNEL; IVABRADINE;

ANIMAL; CHEMISTRY; CONGESTIVE HEART FAILURE; DRUG EFFECT; HEART FAILURE; HEART MUSCLE; HEART MUSCLE CONDUCTION SYSTEM; HEART OUTPUT; HEART RATE; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; REVIEW; SINUS NODE;

ANIMALS; BENZAZEPINES; CARDIAC OUTPUT; CARDIOTONIC AGENTS; HEART CONDUCTION SYSTEM; HEART FAILURE; HEART FAILURE, CONGESTIVE; HEART RATE; HUMANS; ION CHANNELS; MYOCARDIUM; RATS; SINOATRIAL NODE;

EID: 33747884936     PISSN: 00652326     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000095431     Document Type: Review

References (29)

1. Spinale FG, Zellner JL, Tomita M, Crawford FA, Zile MR: Relation between ventricular and myocyte remodeling with the development and regression of supraventricular tachycardia-induced cardiomyopathy. Circ Res 1991;69:1058-1067.
2. Spinale FG, Tomita M, Zellner JL, Cook JC, Crawford FA, Zile MR: Collagen remodeling and changes in LV function during development and recovery from supraventricular tachycardia. Am J Physiol 1991;261:H308-H318.
3. Lechat P, Hulot JS, Escolano S, Mallet A, Leizorovicz A, Werhlen-Grandjean M, Pochmalicki G, Dargie H: Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II Trial. Circulation 2001;103:1428-1433.
4. Waagstein F, Bristow MR, Swedberg K, Camerini F, Fowler MB, Silver MA, Gilbert EM, Johnson MR, Goss FG, Hjalmarson A: Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group. Lancet 1993;342:1441-1446.
5. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial. Lancet 1999;353:9-13.
6. Nagatsu M, Spinale FG, Koide M, Tagawa H, DeFreitas G, Cooper G, Carabello BA: Bradycardia and the role of β-blockade in the amelioration of left ventricular dysfunction. Circulation 2000;101:653-659.
7. Brown MD, Hudlicka O: Protective effects of long-term bradycardial pacing against catecholamine-induced myocardial damage in rabbit hearts. Circ Res 1988;62:965-974.
8. Thollon C, Cambarrat C, Vian J, Prost JF, Peglion JL, Vilaine JP: Electrophysiological effects of S 16257, a novel sino-atrial node modulator, on rabbit and guinea-pig cardiac preparations: comparison with UL-FS 49. Br J Pharmacol 1994;112:37-42.
9. Gardiner SM, Kemp PA, March JE, Bennett T: Acute and chronic cardiac and regional haemodynamic effects of the novel bradycardic agent, S16257, in conscious rats. Br J Pharmacol 1995;115:579-586.
10. Simon L, Ghaleh B, Puybasset L, Giudicelli JF, Berdeaux A: Coronary and hemodynamic effects of S 16257, a new bradycardic agent, in resting and exercising conscious dogs. J Pharmacol Exp Ther 1995;275:659-666.
11. Monnet X, Ghaleh B, Colin P, de Curzon OP, Giudicelli JF, Berdeaux A: Effects of heart rate reduction with ivabradine on exercise-induced myocardial ischemia and stunning. J Pharmacol Exp Ther 2001;299:1133-1139.
12. Bois P, Bescond J, Renaudon B, Lenfant J: Mode of action of bradycardic agent, S 16257, on ionic currents of rabbit sinoatrial node cells. Br J Pharmacol 1996;118:1051-1057.
13. Shinke T, Takeuchi M, Takaoka H, Yokoyama M: Beneficial effects of heart rate reduction on cardiac mechanics and energetics in patients with left ventricular dysfunction. Jpn Circ J 1999;63:957-964.
14. Ryu KH, Tanaka N, Ross J Jr: Effects of a sinus node inhibitor on the normal and failing rabbit heart. Basic Res Cardiol 1996;91:131-139.
15. f current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure. Circulation 2004;109:1674-1679.
16. 1-adrenoceptor blockade promotes growth of arterioles and preserves coronary perfusion reserve in postinfarcted heart. Am J Physiol Heart Circ Physiol 2005;288:H2684-H2693.
17. Boudoulas H, Rittgers SE, Lewis RP, Leier CV, Weissler AM: Changes in diastolic time with various pharmacologic agents: implication for myocardial perfusion. Circulation 1979;60:164-169.
18. Guth BD, Heusch G, Seitelberger R, Ross J Jr: Elimination of exercise-induced regional myocardial dysfunction by a bradycardiac agent in dogs with chronic coronary stenosis. Circulation 1987;75:661-669.
19. Nadaud S, Philippe M, Arnal JF, Michel JB, Soubrier F: Sustained increase in aortic endothelial nitric oxide synthase expression in vivo in a model of chronic high blood flow. Circ Res 1996;79:857-863.
20. Varin R, Mulder P, Richard V, Tamion F, Devaux C, Henry JP, Lallemand F, Lerebours G, Thuillez C: Exercise improves flow-mediated vasodilatation of skeletal muscle arteries in rats with chronic heart failure. Role of nitric oxide, prostanoids, and oxidant stress. Circulation 1999;99:2951-2957.
21. Kapadia SR: Cytokines and heart failure. Cardiol Rev 1999;7:196-206.
22. Ide T, Tsutsui H, Kinugawa S, Suematsu N, Hayashidani S, Ichikawa K, Utsumi H, Machida Y, Egashira K, Takeshita A: Direct evidence for increased hydroxyl radicals originating from superoxide in the failing myocardium. Circ Res 2000;86:152-157.
23. Luyt CE, Lepailleur-Enouf D, Gaultier CJ, Valdenaire O, Steg G, Michel JB: Involvement of the endothelin system in experimental critical hind limb ischemia. Mol Med 2000;6:947-956.
24. Anversa P, Beghi C, Kikkawa Y, Olivetti G: Myocardial infarction in rats. Infarct size, myocyte hypertrophy, and capillary growth. Circ Res 1986;58:26-37.
25. Zheng W, Brown MD, Brock TA, Bjercke RJ, Tomanek RJ: Bradycardia-induced coronary angiogenesis is dependent on vascular endothelial growth factor. Circ Res 1999;85:192-198.
26. Lei L, Zhou R, Zheng W, Christensen LP, Weiss RM, Tomanek RJ: Bradycardia induces angiogenesis, increases coronary reserve, and preserves function of the postinfarcted heart. Circulation 2004;110:796-802.
27. Kim CH, Cho YS, Chun YS, Park JW, Kim MS: Early expression of myocardial HIF-1α in response to mechanical stresses: regulation by stretch-activated channels and the phosphatidylinositol 3-kinase signaling pathway. Circ Res 2002;90:E25-E33.
28. Zheng W, Seftor EA, Meininger CJ, Hendrix MJ, Tomanek RJ: Mechanisms of coronary angiogenesis in response to stretch: role of VEGF and TGF-β. Am J Physiol Heart Circ Physiol 2001;280:H909-H917.
29. Kjekshus J: Heart rate reduction - A mechanism of benefit? Eur Heart J 1987;8(suppl L):115-122.